CROSSJECT (ALCJ.PA) Stock Price, Forecast & Analysis
EPA:ALCJ • FR0011716265
ALCJ.PA Key Statistics, Chart & Performance
The current stock price of ALCJ.PA is 2.05 EUR. In the past month the price increased by 4.06%. In the past year, price increased by 13.89%.
ALCJ.PA Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ALCJ.PA. When comparing the yearly performance of all stocks, ALCJ.PA is a bad performer in the overall market: 65.16% of all stocks are doing better.
ALCJ.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to ALCJ.PA. ALCJ.PA may be in some trouble as it scores bad on both profitability and health.
ALCJ.PA Financial Highlights
Over the last trailing twelve months ALCJ.PA reported a non-GAAP Earnings per Share(EPS) of -0.23. The EPS increased by 13.8% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.89% | ||
| ROE | -308.38% | ||
| Debt/Equity | 2.52 |
ALCJ.PA Forecast & Estimates
10 analysts have analysed ALCJ.PA and the average price target is 4.11 EUR. This implies a price increase of 100.68% is expected in the next year compared to the current price of 2.05.
For the next year, analysts expect an EPS growth of 135.12% and a revenue growth 428.62% for ALCJ.PA
ALCJ.PA Ownership
ALCJ.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ESL | ESSILORLUXOTTICA | 28.15 | 104.843B | ||
| 1EL | ESSILORLUXOTTICA | 28.04 | 104.426B | ||
| EL | ESSILORLUXOTTICA | 28.02 | 104.333B | ||
| GBT | GUERBET | 94.48 | 168.87M | ||
| CVX | CARVOLIX SA | N/A | 137.332M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 51.584M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About ALCJ.PA
Company Profile
Crossject SA manufactures and markets needle free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 103 full-time employees. The company went IPO on 2014-02-20. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The firm has industrial partnerships with Hirtenberger and Recipharm. The company provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Company Info
CROSSJECT
Parc Mazen-Sully, 6 Rue Pauline Kergomard
Dijon BOURGOGNE-FRANCHE-COMTE FR
Employees: 106
Phone: 33380549850
CROSSJECT / ALCJ.PA FAQ
What does ALCJ do?
Crossject SA manufactures and markets needle free injection system. The company is headquartered in Dijon, Bourgogne-Franche-Comte and currently employs 103 full-time employees. The company went IPO on 2014-02-20. The firm specializes in needle-free, pre-filled, single-use injection systems for intradermal, subcutaneous, and intramuscular applications for pharmaceutical companies. Is also has a pipeline and three drugs in the preclinical or clinical phase of research. The firm's products, which are based on well-known injectable drugs (chemicals and biologics), are designed to enhance patients' safety, compliance, and comfort. The firm has industrial partnerships with Hirtenberger and Recipharm. The company provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Can you provide the latest stock price for CROSSJECT?
The current stock price of ALCJ.PA is 2.05 EUR. The price decreased by -2.38% in the last trading session.
Does ALCJ stock pay dividends?
ALCJ.PA does not pay a dividend.
What is the ChartMill rating of CROSSJECT stock?
ALCJ.PA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy ALCJ stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ALCJ.PA.
What is the ownership structure of CROSSJECT (ALCJ.PA)?
You can find the ownership structure of CROSSJECT (ALCJ.PA) on the Ownership tab.